Platelets, Thrombocytosis, and Ovarian Cancer Prognosis: Surveying the Landscape of the Literature

by Demetra H. Hufnagel, Gabriella D. Cozzi, Marta A. Crispens, Alicia Beeghly-Fadiel
Published 2020-10-01

Incidental placenta increta at the time of prophylactic hysterectomy for Lynch syndrome: Insights into individualized decision-making and surgical timing

by Tara A. Nielsen, Stephanie N. David, Mohamed M. Desouki, Marta A. Crispens, Dineo Khabele
Published 2015-11-01

Blood type, ABO genetic variants, and ovarian cancer survival.

by Gabriella D Cozzi, Rebecca T Levinson, Hilary Toole, Malcolm-Robert Snyder, Angie Deng, Marta A Crispens, Dineo Khabele, Alicia Beeghly-Fadiel
Published 2017-01-01

Expression of p52, a non-canonical NF-kappaB transcription factor, is associated with poor ovarian cancer prognosis

by Demetra H. Hufnagel, Andrew J. Wilson, Jamie Saxon, Timothy S. Blackwell, Jaclyn Watkins, Dineo Khabele, Marta A. Crispens, Fiona E. Yull, Alicia Beeghly-Fadiel
Published 2020-09-01

Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors

by Alicia Beeghly-Fadiel, Andrew J. Wilson, Spencer Keene, Meral El Ramahi, Shu Xu, Lawrence J. Marnett, Oluwole Fadare, Marta A. Crispens, Dineo Khabele
Published 2018-02-01

Increased canonical NF-kappaB signaling specifically in macrophages is sufficient to limit tumor progression in syngeneic murine models of ovarian cancer

by Alyssa A. Hoover, Demetra H. Hufnagel, Whitney Harris, Kennady Bullock, Evan B. Glass, Esther Liu, Whitney Barham, Marta A. Crispens, Dineo Khabele, Todd D. Giorgio, Andrew J. Wilson, Fiona E. Yull
Published 2020-10-01